IceCure Medical (ICCM) Competitors

$0.24 0.00 (-2.04%)

As of 01:27 PM Eastern

ICCM vs. OM, QTI, INO, BDMD, and STSS

Should you be buying IceCure Medical stock or one of its competitors? The main competitors of IceCure Medical include Outset Medical (OM), QT Imaging (QTI), Inovio Pharmaceuticals (INO), Baird Medical Investment (BDMD), and Sharps Technology (STSS). These companies are all part of the "medical equipment" industry.

How does IceCure Medical compare to Outset Medical?

Outset Medical (NASDAQ:OM) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

In the previous week, Outset Medical had 3 more articles in the media than IceCure Medical. MarketBeat recorded 12 mentions for Outset Medical and 9 mentions for IceCure Medical. IceCure Medical's average media sentiment score of 0.54 beat Outset Medical's score of -0.09 indicating that IceCure Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Outset Medical	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral
IceCure Medical	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Outset Medical has a net margin of -63.65% compared to IceCure Medical's net margin of -445.61%. Outset Medical's return on equity of -56.13% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Outset Medical	-63.65%	-56.13%	-27.45%
IceCure Medical	-445.61%	-221.04%	-118.89%

Outset Medical presently has a consensus price target of $10.00, suggesting a potential upside of 156.41%. IceCure Medical has a consensus price target of $2.64, suggesting a potential upside of 1,020.80%. Given IceCure Medical's higher probable upside, analysts clearly believe IceCure Medical is more favorable than Outset Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Outset Medical	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.67
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

IceCure Medical has lower revenue, but higher earnings than Outset Medical. IceCure Medical is trading at a lower price-to-earnings ratio than Outset Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Outset Medical	$119.48M	0.61	-$81.65M	-$4.16	N/A
IceCure Medical	$3.38M	5.65	-$15.06M	-$0.24	N/A

0.6% of IceCure Medical shares are held by institutional investors. 2.5% of Outset Medical shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Outset Medical has a beta of 1.92, meaning that its share price is 92% more volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.47, meaning that its share price is 53% less volatile than the broader market.

Summary

Outset Medical beats IceCure Medical on 11 of the 17 factors compared between the two stocks.

How does IceCure Medical compare to QT Imaging?

IceCure Medical (NASDAQ:ICCM) and QT Imaging (NASDAQ:QTI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and risk.

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 28.8% of QT Imaging shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

IceCure Medical has a beta of 0.47, suggesting that its stock price is 53% less volatile than the broader market. Comparatively, QT Imaging has a beta of 0.01, suggesting that its stock price is 99% less volatile than the broader market.

QT Imaging has a net margin of -111.40% compared to IceCure Medical's net margin of -445.61%. QT Imaging's return on equity of 0.00% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-445.61%	-221.04%	-118.89%
QT Imaging	-111.40%	N/A	-115.44%

IceCure Medical has higher earnings, but lower revenue than QT Imaging. QT Imaging is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	5.65	-$15.06M	-$0.24	N/A
QT Imaging	$18.92M	4.59	-$21.08M	-$2.19	N/A

IceCure Medical currently has a consensus price target of $2.64, suggesting a potential upside of 1,020.80%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts plainly believe IceCure Medical is more favorable than QT Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
QT Imaging	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, IceCure Medical had 7 more articles in the media than QT Imaging. MarketBeat recorded 9 mentions for IceCure Medical and 2 mentions for QT Imaging. QT Imaging's average media sentiment score of 1.01 beat IceCure Medical's score of 0.54 indicating that QT Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IceCure Medical	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
QT Imaging	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IceCure Medical beats QT Imaging on 9 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to Inovio Pharmaceuticals?

IceCure Medical (NASDAQ:ICCM) and Inovio Pharmaceuticals (NASDAQ:INO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends.

IceCure Medical has a beta of 0.47, meaning that its share price is 53% less volatile than the broader market. Comparatively, Inovio Pharmaceuticals has a beta of 1.43, meaning that its share price is 43% more volatile than the broader market.

IceCure Medical has higher revenue and earnings than Inovio Pharmaceuticals. IceCure Medical is trading at a lower price-to-earnings ratio than Inovio Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IceCure Medical	$3.38M	5.65	-$15.06M	-$0.24	N/A
Inovio Pharmaceuticals	$60K	1,689.71	-$84.95M	-$1.68	N/A

Inovio Pharmaceuticals has a net margin of 0.00% compared to IceCure Medical's net margin of -445.61%. IceCure Medical's return on equity of -221.04% beat Inovio Pharmaceuticals' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IceCure Medical	-445.61%	-221.04%	-118.89%
Inovio Pharmaceuticals	N/A	-259.70%	-83.46%

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 26.8% of Inovio Pharmaceuticals shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by company insiders. Comparatively, 1.7% of Inovio Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

IceCure Medical currently has a consensus price target of $2.64, suggesting a potential upside of 1,020.80%. Inovio Pharmaceuticals has a consensus price target of $6.75, suggesting a potential upside of 362.33%. Given IceCure Medical's higher possible upside, equities analysts clearly believe IceCure Medical is more favorable than Inovio Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Inovio Pharmaceuticals	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

In the previous week, Inovio Pharmaceuticals had 3 more articles in the media than IceCure Medical. MarketBeat recorded 12 mentions for Inovio Pharmaceuticals and 9 mentions for IceCure Medical. Inovio Pharmaceuticals' average media sentiment score of 0.60 beat IceCure Medical's score of 0.54 indicating that Inovio Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IceCure Medical	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inovio Pharmaceuticals	4 Very Positive mention(s)	4 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Inovio Pharmaceuticals beats IceCure Medical on 10 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMD) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, dividends, media sentiment, risk, profitability, earnings and institutional ownership.

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Baird Medical Investment has a beta of -1.18, meaning that its stock price is 218% less volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.47, meaning that its stock price is 53% less volatile than the broader market.

Baird Medical Investment has a net margin of 0.00% compared to IceCure Medical's net margin of -445.61%. Baird Medical Investment's return on equity of 0.00% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baird Medical Investment	N/A	N/A	N/A
IceCure Medical	-445.61%	-221.04%	-118.89%

In the previous week, IceCure Medical had 7 more articles in the media than Baird Medical Investment. MarketBeat recorded 9 mentions for IceCure Medical and 2 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 1.44 beat IceCure Medical's score of 0.54 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company	Overall Sentiment
Baird Medical Investment	Positive
IceCure Medical	Positive

IceCure Medical has a consensus price target of $2.64, suggesting a potential upside of 1,020.80%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts clearly believe IceCure Medical is more favorable than Baird Medical Investment.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baird Medical Investment	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Baird Medical Investment has higher revenue and earnings than IceCure Medical.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baird Medical Investment	$22.54M	3.11	N/A	N/A	N/A
IceCure Medical	$3.38M	5.65	-$15.06M	-$0.24	N/A

Summary

Baird Medical Investment beats IceCure Medical on 7 of the 13 factors compared between the two stocks.

How does IceCure Medical compare to Sharps Technology?

Sharps Technology (NASDAQ:STSS) and IceCure Medical (NASDAQ:ICCM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends and profitability.

17.2% of Sharps Technology shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 1.2% of Sharps Technology shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sharps Technology has a beta of 2.03, meaning that its stock price is 103% more volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.47, meaning that its stock price is 53% less volatile than the broader market.

Sharps Technology has a net margin of 0.00% compared to IceCure Medical's net margin of -445.61%. Sharps Technology's return on equity of -145.56% beat IceCure Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sharps Technology	N/A	-145.56%	-140.36%
IceCure Medical	-445.61%	-221.04%	-118.89%

In the previous week, IceCure Medical had 7 more articles in the media than Sharps Technology. MarketBeat recorded 9 mentions for IceCure Medical and 2 mentions for Sharps Technology. Sharps Technology's average media sentiment score of 0.93 beat IceCure Medical's score of 0.54 indicating that Sharps Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Sharps Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IceCure Medical	1 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IceCure Medical has a consensus price target of $2.64, suggesting a potential upside of 1,020.80%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Sharps Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sharps Technology	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IceCure Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

IceCure Medical has higher revenue and earnings than Sharps Technology. IceCure Medical is trading at a lower price-to-earnings ratio than Sharps Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sharps Technology	$200K	397.33	-$282.50M	-$831.83	N/A
IceCure Medical	$3.38M	5.65	-$15.06M	-$0.24	N/A

Summary

IceCure Medical beats Sharps Technology on 9 of the 16 factors compared between the two stocks.

Get IceCure Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ICCM vs. The Competition

Export

Metric	IceCure Medical	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$19.09M	$8.30B	$6.28B	$12.04B
Dividend Yield	N/A	2.86%	2.78%	5.23%
P/E Ratio	-0.98	23.03	20.49	25.22
Price / Sales	5.65	16.36	544.52	74.60
Price / Cash	N/A	12.66	27.81	36.29
Price / Book	1.96	4.93	9.58	6.58
Net Income	-$15.06M	$183.43M	$3.55B	$333.40M
7 Day Performance	-17.42%	1.89%	-0.82%	-0.99%
1 Month Performance	-27.28%	7.62%	5.46%	7.15%
1 Year Performance	-75.76%	-0.15%	37.70%	34.19%

IceCure Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ICCM IceCure Medical	2.8939 of 5 stars	$0.24 -2.0%	$2.64 +1,020.8%	-76.7%	$19.09M	$3.38M	N/A	60	News Coverage Gap Down
OM Outset Medical	2.5499 of 5 stars	$4.64 +7.0%	$10.00 +115.7%	-76.1%	$85.90M	$119.48M	N/A	520	Earnings Report
QTI QT Imaging	0.8295 of 5 stars	$6.89 +5.4%	N/A	+731.4%	$82.91M	$18.93M	N/A	N/A	Positive News Upcoming Earnings
INO Inovio Pharmaceuticals	1.9624 of 5 stars	$1.18 +3.1%	$6.75 +474.5%	-21.2%	$81.59M	$60K	N/A	320	News Coverage
BDMD Baird Medical Investment	1.7275 of 5 stars	$1.81 +0.6%	N/A	-67.6%	$74.17M	$22.54M	N/A	N/A	Positive News Short Interest Decrease

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ICCM) was last updated on 5/12/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IceCure Medical (ICCM) Competitors

ICCM vs. OM, QTI, INO, BDMD, and STSS

How does IceCure Medical compare to Outset Medical?

Summary

How does IceCure Medical compare to QT Imaging?

Summary

How does IceCure Medical compare to Inovio Pharmaceuticals?

Summary

How does IceCure Medical compare to Baird Medical Investment?

Summary

How does IceCure Medical compare to Sharps Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICCM vs. The Competition

IceCure Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

IceCure Medical (ICCM) Competitors

ICCM vs. OM, QTI, INO, BDMD, and STSS

How does IceCure Medical compare to Outset Medical?

Does the media prefer OM or ICCM?

Is OM or ICCM more profitable?

Do analysts rate OM or ICCM?

Which has higher valuation and earnings, OM or ICCM?

Do institutionals & insiders have more ownership in OM or ICCM?

Which has more risk and volatility, OM or ICCM?

Summary

How does IceCure Medical compare to QT Imaging?

Do insiders and institutionals hold more shares of ICCM or QTI?

Which has more volatility and risk, ICCM or QTI?

Is ICCM or QTI more profitable?

Which has higher valuation and earnings, ICCM or QTI?

Do analysts prefer ICCM or QTI?

Does the media favor ICCM or QTI?

Summary

How does IceCure Medical compare to Inovio Pharmaceuticals?

Which has more risk and volatility, ICCM or INO?

Which has stronger earnings and valuation, ICCM or INO?

Is ICCM or INO more profitable?

Do institutionals and insiders hold more shares of ICCM or INO?

Do analysts prefer ICCM or INO?

Does the media refer more to ICCM or INO?

Summary

How does IceCure Medical compare to Baird Medical Investment?

Do insiders & institutionals hold more shares of BDMD or ICCM?

Which has more risk & volatility, BDMD or ICCM?

Is BDMD or ICCM more profitable?

Does the media refer more to BDMD or ICCM?

Do analysts rate BDMD or ICCM?

Which has higher earnings & valuation, BDMD or ICCM?

Summary

How does IceCure Medical compare to Sharps Technology?

Do institutionals & insiders hold more shares of STSS or ICCM?

Which has more volatility & risk, STSS or ICCM?

Is STSS or ICCM more profitable?

Does the media prefer STSS or ICCM?

Do analysts recommend STSS or ICCM?

Which has better valuation & earnings, STSS or ICCM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ICCM vs. The Competition

IceCure Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools